Emend (Aprepitant Capsules) and Insulin Glargine (U-300) Pens
Determining the interaction of Emend (Aprepitant Capsules) and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Emend, Cinvanti, Emend 3-Day, Emend 2-Day
Synonyms: Emend
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend (Aprepitant Capsules)-Insulin glargine and lixisenatide
- Emend (Aprepitant Capsules)-Insulin glargine and lixisenatide Subcutaneous
- Emend (Aprepitant Capsules)-Insulin glargine, recombinant Subcutaneous
- Emend (Aprepitant Capsules)-Insulin glulisine
- Emend (Aprepitant Capsules)-Insulin Glulisine (Cartridges and Pens)
- Emend (Aprepitant Capsules)-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Emend (Aprepitant Oral Suspension)
- Insulin Glargine (U-300) Pens-Emend (Fosaprepitant)
- Insulin Glargine (U-300) Pens-Emend for Injection
- Insulin Glargine (U-300) Pens-Emend Intravenous
- Insulin Glargine (U-300) Pens-Emflaza
- Insulin Glargine (U-300) Pens-Emflaza (Deflazacort Oral Suspension)